|
KMID : 0032220160280040486
|
|
Annals of Dermatology
2016 Volume.28 No. 4 p.486 ~ p.490
|
|
|
Increased Infiltration of CD8+ T Cells by Dacarbazine in a Patient with Mucosal Penile Melanoma Refractory to Nivolumab
|
|
Masato Funazumi
Takeshi Namiki
Yumi Arima
Kohei Kato
Kohei Nojima
Kentaro Tanaka
Keiko Miura
Hiroo Yokozeki
|
|
|
Abstract
|
|
|
|
Primary penile melanomas are rare tumors that represent less than 0.1% of all melanomas. We report a case of a 60-year-old Japanese male with a mucosal penile melanoma and describe an increased CD8+ T cell infiltration in brain after dacarbazine (DTIC) administration. After partial penectomy and left inguinal lymphadenectomy, he developed multiple lung, bone, spleen, brain and skin metastases. He was treated with interferon-β, DTIC and nivolumab. However, the metastases were not reduced in size. Immunohistochemistry showed an increase of CD8+ T cell infiltration and programmed death-ligand 1 (PD-L1) expression after the administration of DTIC, but the expression of programmed cell death protein 1 (PD-1) was negative. We speculate that DTIC exerted immunostimulatory effects, but nivolumab was ineffective due to the negative expression of PD-1 and/or an insufficient infiltration of CD8+ T cells. Although this is only one case, this case report could be the first step to discuss the development of effective therapies against melanoma to take advantage of the increased CD8+ T cell infiltration elicited by chemotherapeutic agents. It would be beneficial to pay more attention to the relationship between DTIC and immune checkpoint modulators.
|
|
|
KEYWORD
|
|
|
CD8, Dacarbazine, Melanoma, Nivolumab, T-lymphocytes
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|